symbol,statement_type,period_end,line_item,value
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,192837000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,0.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-154264000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,End Cash Position,65594000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,99217000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,-33623000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,-258980000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-84923000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-46020000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,0.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,0.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,-128037000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,-46415000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Payments,
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,-81622000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-121744000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,11198000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Dividends Received Cfi,4282000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,218000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-137442000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,16822000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-154264000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,347101000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-107502000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-51085000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,43672000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,-14149000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Change In Payable,41452000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-137402000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,8431000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,84923000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,99287000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Depreciation,99287000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-15144000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,7000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,-880000.0
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of Business,
THEMISMED.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,396749000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,36757000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,415000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-184179000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,End Cash Position,99217000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,125465000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,-26248000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-87704000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-76275000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-46014000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,415000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,415000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,38361000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,55076000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Payments,
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,-16715000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-159480000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,8393000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Dividends Received Cfi,16057000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,0.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,0.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-183930000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,249000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-184179000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,220936000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-89562000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-209163000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,30274000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,27160000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Change In Payable,72476000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-16223000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,-329215000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,76275000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,122463000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,2184000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Depreciation,122463000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-25353000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,72000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,-174000.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of Business,0.0
THEMISMED.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,534432000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,-126554000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,837000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-287479000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,End Cash Position,125465000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,202793000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,-77328000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,1362000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-79902000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-46001000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,837000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,837000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,134063000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,88428000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Short Term Debt Payments,
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,45635000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-239615000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,5473000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Dividends Received Cfi,42051000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,0.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,0.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-287139000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,340000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-287479000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,160925000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-161548000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-402961000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,76591000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,-40538000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Change In Payable,81709000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,-81426000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-444612000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,79902000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,104948000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,2184000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Depreciation,102764000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,-48053000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-117000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,-212000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of Business,1000.0
THEMISMED.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,725149000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,137668000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,3955000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-206273000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,End Cash Position,202793000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,190180000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,12613000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-175469000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-65369000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-39558000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,3955000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,3955000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-66066000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,-82917000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Short Term Debt Payments,
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,16851000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-155859000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,6055000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Dividends Received Cfi,31133000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,0.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,0.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-193047000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,13226000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-206273000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,343941000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-180737000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-425529000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,-146160000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,-36915000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Change In Payable,10815000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-23150000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-229534000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,65369000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,94798000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,2184000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Depreciation,92614000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,-37527000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,0.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,-11650000.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of Business,0.0
THEMISMED.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,952620000.0
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,-196855000.0
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,72569000.0
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,1000.0
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Short Term Debt Payments,-196855000.0
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,72569000.0
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Dividends Received Cfi,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,0.0
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,2184000.0
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Depreciation,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of Business,
THEMISMED.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
